Recent progress in P-glycoprotein research

Anti-Cancer Drug Design

Volumn 14, Issue 2, 1999, Pages 115-121

  Ueda, Kazumitsu ^a   Yoshida, Aya ^a   Amachi, Teruo ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

MDR1; Multidrug resistance; P glycoprotein

Indexed keywords

GLYCOPROTEIN P;

INTRACELLULAR TRANSPORT; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN STRUCTURE; REVIEW; STRUCTURE ACTIVITY RELATION;

ANIMALS; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; GENE THERAPY; HUMANS; NEOPLASMS; P-GLYCOPROTEIN;

EID: 0032969432     PISSN: 02669536     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. Akabas M.H., Kaufmann C., Cook T.A., Archdeacon P. (1994) Amino acid residues lining the chloride channel of the cystic fibrosis transmembrane conductance regulator. Journal of Biological Chemistry, 269, 14865.
2. Anderson M.P., Gregory R.J., Thompson S., Souza D.W., Paul S., Mulligan R.C., Smith A.E., Welsh M.J. (1991) Demonstration that CFTR is a chloride channel by alteration of its anion selectivity. Science, 253, 202.
3. Boesch D., Gaveriaux C., Jachez B., Pourtier-Manzanedo A., Bollinger P., Loor F. (1991) In vivo circumvention of P-glycoprotein-mediated multidrug resistance of tumor cells with SDZ PSC833. Cancer Research, 51, 4226.
4. Bruggemann E.P., Germann U.A., Gottesman M.M., Pastan I. (1989) Two different regions of phosphoglycoprotein are photoaffinity-labeled by azidopine. Journal of Biological Chemistry, 264, 15483.
5. Chaudhary P.M., Roninson I.B. (1991) Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell, 66, 85.
6. Chen C., Chin J.E., Ueda K., Clark D.P., Pastan I., Gottesman M.M., Roninson I.B. (1986) Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell, 47, 381.
7. Essodaigui M., Broxterman H., Garnier-Suilerot A. (1998) Kinetic analysis of calcein and calcein-acetoxymethylester efflux mediated by the multidrug resistance protein and P-glycoprotein. Biochemistry, 37, 2243.
8. Greenberger L.M. (1993) Major photoaffinity drug labeling sites for iodoaryl azidoprazosin in P-glycoprotein are within, or immediately C-terminal to, transmembrane domains 6 and 12. Journal of Biological Chemistry, 268, 11417.
9. Gros P., Croop J., Housman D. (1986a) Mammalian multidrug resistance gene: complete cDNA sequence indicates strong homology to bacterial transport protein. Cell, 47, 371.
10. Gros P., Niriah Y.B., Croop J.M., Housman D.E. (1986b) Isolation and expression of a complementary DNA that confers multidrug resistance. Nature, 323, 728.
11. Hanania E.G., Deisseroth A.B. (1994) Serial transplantation shows that early hematopoietic precursor cells are transduced by MDR1 retroviral vector in a mouse gene therapy model. Cancer Gene Therapy, 1, 21.
12. Helvoort A.v., Smith A.J., Sprong H., Fritzsche I., Schinkel A.H., Borst P., Meer G.v. (1996) MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine. Cell, 87, 507.
13. Hesdorffer C., Antman K., Bank A., Fetell M., Mears G., Begg M. (1994) Human MDR gene transfer in patients with advanced cancer. Human Gene Therapy, 5, 1151.
14. Higgins C.F. (1992) ABC transporters: from microorganisms to man. Annual Review of Cell Biology, 8, 67.
15. Higgins C.F., Gottesman, M.M. (1992) Is the multidrug transporter a flippase? Trends in Biochemical Science, 17, 18.
16. Higgins C.F., Callaghan R., Linton K.J., Rosenberg M.F., Ford R.C. (1997) Multidrug resistance protein - structure of the multidrug resistant P-glycoprotein. In Seminars in Cancer Biology. Borst, P. (ed.). Academic Press: London.
17. Homolya L., Hollo Z., Germann U.A., Pastan I., Gottesman M.M., Sarkadi B. (1993) Fluorescent cellular indicators are extruded by the multidrug resistance protein. Journal of Biological Chemistry, 268, 21493.
18. Hyde S.C., Emsley P., Hartshorn M.J., Mimmack M.M., Gileadi U., Pearce S.R., Gallagher M.P., Gill D.R., Hubbard R.E., Higgins C.F. (1990) Structural model of ATP-binding proteins associated with cystic fibrosis, multidrug resistance and bacterial transport. Nature, 346, 362.
19. Inaba M., Kobayashi H., Sakurai Y., Johnson R.K. (1979) Active efflux of daunorubicin and adriamycin in sensitive and resistant sublines of P388 leukemia. Cancer Research, 39, 2200.
20. Juliano R.L., Ling V. (1976) A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochimica Biophysica Acta, 455, 152.
21. Kino K., Taguchi Y., Yamada K., Komano T., Ueda K. (1996) Aureobasidin A, an antifungal cyclic depsipeptide antibiotic, is a substrate for both human MDR1 and MDR2/P-glycoproteins. FEBS Letters, 399, 29.
22. Kusunoki N., Takara K., Tanigawara Y., Yamauchi A., Ueda K., Komada F., Ku Y., Kuroda Y., Saitoh Y., Okumura K. (1998) Inhibitory effects of a cyclosporin derivative, SDZ PSC 833, on transport of doxorubicin and vinblastine via human P-glycoprotein. Japanese Journal of Cancer Research, 89, 1220.
23. Loo T.W., Clarke D.M. (1994) Reconstitution of drug-stimulated ATPase activity following co-expression of each half of human P-glycoprotein as separate polypeptides. Journal of Biological Chemistry, 269, 7750.
24. Loo T.W., Clarke D.M. (1996) Inhibition of oxidative cross-linking between engineered cysteine residues at positions 332 in predicted transmembrane segments (TM) 6 and 975 in predicted TM12 of human P-glycoprotein by drug substrates. Journal of Biological Chemistry, 271, 27482.
25. Pastan I., Gottesman M.M., Ueda K., Lovelace E., Rutherford A.V., Willingham M.C. (1988) A retrovirus carrying an MDR1 cDNA confers multidrug resistance and polarized expression of P-glycoprotein in MDCK cells. Proceedings of the National Academy of Sciences, USA, 85, 4486.
26. Rosenberg M.F., Callaghan R., Ford R.C., Higgins C.F. (1997) Structure of the multidrug resistance P-glycoprotein to 2.5 nm resolution determined by electron microscopy and image analysis. Journal of Biological Chemistry, 272, 10685.
27. Saeki T., Ueda K., Tanigawara Y., Hori R., Komano T. (1993) Human P-glycoprotein transports cyclosporin A and FK506. Journal of Biological Chemistry, 268, 6077.
28. Senior A.E., Gadsby D.C. (1997) Multidrug resistance proteins-ATP hydrolysis cycles and mechanism in P-glycoprotein and CFTR. In Seminars in Cancer Biology. Borst, P. (ed.), pp. 143-150. Academic Press: London.
29. Shimabuku A.M., Nishimoto T., Ueda K., Komano T. (1992) P-glycoprotein: ATP hydrolysis by the N-terminal nucleotide-binding domain. Journal of Biological Chemistry, 267, 4308.
30. Smit J.J.M., Schinkel A.H., Oude Elferink R.P.J., Groen A.K., Wagenaar E., van Deemter L., Mol C.A., Ottenhoff R., van der Lugt N.M.T., van Roon M.A., van der Valk M.A., Offerhaus G.J.A., Berns A.J.M., Borst P. (1993) Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell, 75, 451.
31. Sugimoto Y., Gottesman M.M., Pastan I., Tsuruo T. (1996) Application of the MDR1 gene for human gene therapy. In Multidrug Resistance in Cancer Cells. Gupta S. and Tsuruo T. (eds), pp. 435-449. John Wiley: Chichester.
32. Taguchi Y., Kino K., Morishima M., Komano T., Kane S.E., Ueda K. (1997a) Alteration of substrate specificity by mutations at the His61 position in predicted transmembrane domain 1 of human MDR1/P-glycoprotein. Biochemistry, 36, 8883.
33. Taguchi Y., Morishima M., Komano T., Ueda K. (1997b) Amino acid substitutions in the first transmembrane domain (TM1) of P-glycoptotein alter substrate specificity. FEBS Letters, 413, 142.
34. Taguchi Y., Yoshida A., Takada Y., Komano T., Ueda K. (1997c) Anti-cancer drugs and glutathione stimulate vanadate-induced trapping of nucleotide in multidrug resistance-associated protein (MRP). FEBS Letters, 401, 11.
35. Takada Y., Yamada K., Taguchi Y., Kino K., Matsuo M., Tucker S.J., Komano T., Amachi T., Ueda K. (1998) Non-equivalent cooperation between the two nucleotide-binding folds of P-glycoprotein. Biochimica Biophysics Acta, 1373, 131.
36. Tsuruo T., Iida H., Tsukagosi S., Sakurai Y. (1981) Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Research, 41, 1967.
37. Ueda K., Cornwell M.M., Gottesman M.M., Pastan I., Roninson I.B., Ling V., Riordan J.R. (1986) The mdr1 gene, responsible for multidrug-resistance, codes for P-glycoprotein. Biochemical and Biophysical Research Communications, 141, 956.
38. Ueda K., Cardarelli C., Gottesman M.M., Pastan I. (1987a) Expression of full-length cDNA for the human 'MDR1' gene confers resistance to colchicine, doxorubicin, and vinblastine. Proceedings of the National Academy of Science, USA, 84, 3004.
39. Ueda K., Clark D.P., Chen C.-j., Roninson I.B., Gottesman M.M., Pastan I. (1987b) The human multidrug resistance (mdr1) gene. Journal of Biological Chemistry, 262, 505.
40. Ueda K., Inagaki N., Seino S. (1997) MgADP antagonism to Mg-independent ATP binding of the sulfonylurea receptor SUR1. Journal of Biological Chemistry, 272, 22983.
41. Ueda K., Komine J., Matsuo M., Seino S., Amachi T. (1999) Cooperative binding of ATP and MgADP in the sulfonylurea receptor is modulated by glibenclamide. Proceedings of the National Academy of Sciences, USA, 96, in press.
42. Ueda K., Taguchi Y., Morishima M. (1997) Multidrug resistance proteins - how does P-gp recognize its substrates? In Seminars in Cancer Biology. Borst, P. (ed.), pp. 151-160. Academic Press: London.
43. Urbatsch I.L., Sankaran B., Bhagat S., Senior A.E. (1995) Both P-glycoprotein nucleotide-binding sites are catalytically active. Journal of Biological Chemistry, 270, 26956.
44. Wu Q., Bounaud P., Kuduk S., Yang C., Ojima I., Horwitz S., Orr, G. (1998) Identification of the domains of photoincorporation of the 3′-and 7-benzophenone analogues of taxol in the carboxyl-terminal half of murine mdr1b P-glycoprotein. Biochemistry, 37, 11272.
45. Yoshimura A., Kuwazuru Y., Sumizawa T., Ichikawa M., Ikeda S., Uda T., Akiyama S. (1989) Cytoplasmic orientation and two-domain structure of the multidrug transporter, P-glycoprotein, demonstrated with sequence-specific antibodies. Journal of Biological Chemistry, 264, 16282.